Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2024
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate CancerNaiyu Chen, Colleen B McGrath, Caroline I Ericsson, et al.
Nature Communications|February 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancerDavid C Müller, Andrew J Murtha, Jack V W Bacon, et al.
Nature Medicine|November 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trialLindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.
Elife|March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Science (New York, N.Y.)|June 23, 2022
Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new functionMaurice Michel, Carlos Benítez-Buelga, Patricia A Calvo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4Andrew J Armstrong, Michael J Morris, Wassim Abida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2025
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancerT Virtanen, E M Kwan, K Parekh, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Pageof 41